La vendita allo scoperto per CNO Finl Group dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di CNO Finl Group. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

CNO Finl Group (NYSE:CNO) Azioni, Report sulle vendite allo scoperto

CNO Finl Group

CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.

CNO Financial Group Inc

ConnectOne Bancorp Inc

HEMLO EXPLORERS INC by HEMLO EXPLORERS INC.

Hemlo Explorers Inc

ConnectOne Bancorp, Inc. - Depositary Shares (each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A, par value $0.00 per share)

LYNX GLOBAL DIGITAL FIN by LYNX GLOBAL DIGITAL FIN CORP

Lynx Global Digital Finance Corp

CNO Financial Group, Inc. 5.125% Subordinated Debentures due 2060

RBC Capital analyst Scott Heleniak maintains CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Outperform and raises the price target from $38 to $40.

News

Price Target

Analyst Ratings

RBC Capital Maintains Outperform on CNO Finl Group, Raises Price Target to $40

CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.82 by 14.63 percent. The company reported quarterly sales of $1.130 billion which beat the analyst consensus estimate of $945.442 million by 19.52 percent. This is a 19.26 percent increase over sales of $947.500 million the same period last year.

Earnings

Earnings Beats

CNO Finl Group Q3 2024 Adj. EPS $0.94 Beats $0.82 Estimate, Sales $1.130B Beat $945.442M Estimate

5 analysts have shared their evaluations of CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.6, a high estimate of $38.00, and a low estimate of $29.00. Witnessing a positive shift, the current average has risen by 7.45% from the previous average price target of $32.20.
<img src="https://www.benzinga.com/files/images/story/2024/1727877675_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of CNO Finl Group by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$38.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Underperform</td>
<td>$29.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$31.00</td>
<td>$30.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CNO Finl Group. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of CNO Finl Group compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for CNO Finl Group's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into CNO Finl Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CNO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CNO Finl Group analyst ratings.</a>
<h2>All You Need to Know About CNO Finl Group</h2>
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
<h3>Breaking Down CNO Finl Group's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, CNO Finl Group showcased positive performance, achieving a revenue growth rate of 4.24% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: CNO Finl Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 10.91%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.85%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): CNO Finl Group's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.33%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.86, caution is advised due to increased financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For CNO Finl Group's Future

Piper Sandler analyst John Barnidge maintains CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Overweight and raises the price target from $37 to $38.

Piper Sandler Maintains Overweight on CNO Finl Group, Raises Price Target to $38

MetLife, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/met#NYSE">MET</a>) benefits on the back of a well-performing Group Benefits business, acquisitions and partnerships, cost-cutting efforts and strong cash balance.
<h2>Zacks Rank &amp; Price Performance</h2>
MetLife carries a Zacks Rank #2 (Buy) at present.
The stock has gained 10% in the past three months compared with the industry&#39;s growth of 5.3%. The Zacks Finance sector and the S&amp;P 500 composite index have returned 0.8% and 2.4%, respectively, in the said time frame.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c8/77767.jpg?v=1023352585" />
Image Source: Zacks Investment Research
<h2>Favorable Style Score</h2>
MetLife carries an impressive Value Score of A. Value Score helps find stocks that are undervalued. Back-tested results show that stocks with a Value Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, offer the best opportunities in the value investing space.
<h2>Robust Growth Prospects</h2>
The Zacks Consensus Estimate for MetLife&#39;s 2024 earnings is pegged at $8.67 per share, which indicates an improvement of 18.3% from the 2023 reported figure. The consensus mark for revenues is $73.2 billion, implying a rise of 2% from the 2023 figure. MET&#39;s earnings estimates witnessed seven upward revisions over the past 60 days against no downward movement.
The consensus mark for 2025 earnings is pegged at $9.83 per share, suggesting an improvement of 13.4% from the 2024 estimate. The same for revenues is $76.5 billion, hinting at a 4.6% increase from the 2024 estimate.
<h2>Valuation</h2>
Price-to-book (P/B) is one of the multiples used for valuing insurance stocks. Compared with the multiline industry&#39;s trailing 12-month P/B ratio of 2.57, MetLife has a reading of 1.92. It is quite evident that the stock is currently undervalued.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/0a/77768.jpg?v=1057971813" />
Image Source: Zacks Investment Research
<h2>Solid Return on Equity</h2>
Return on equity in the trailing 12 months is currently 21.4%, which is higher than the industry&#39;s average of 16.2%. This substantiates the company&#39;s efficiency in utilizing shareholders&#39; funds.
<h2>Business Tailwinds</h2>
A key revenue contributor is MetLife&#39;s steady premiums, which have been recovering from pandemic-driven declines. Premiums are witnessing a steady increase in the Group Benefits business, wherein it rose 4% year over year in the first half of 2024. Growth has also been robust in its EMEA and Latin America segments, further contributing to the company&#39;s revenue stream.
MetLife&#39;s focus on streamlining its business, coupled with strategic acquisitions and partnerships, is expected to drive long-term growth. The company has expanded its presence in key areas like vision care and pet insurance through acquisitions, such as Versant Health and PetFirst. It has also strengthened its benefits offerings through partnerships with firms like Aura and Nayya.
A strategic push into private credit investments, marked by the acquisition of Raven Capital, and a collaboration with Fidelity Investments on a fixed immediate income annuity further diversify its business portfolio. Additionally, MetLife continues to reduce volatility by divesting capital-intensive units and intensifying focus on high-growth areas. &nbsp;
MetLife&#39;s cost-saving measures have resulted in notable operational improvements. Between 2015 and 2020, the company saw an improvement of 230 basis points in its direct expense ratio. This efficiency trend has continued, with the direct expense ratio remaining below the guided 12.3% in the first half of 2024.
MetLife also benefits from a strong liquidity position, with short-term debt of $390 million as of June 30, 2024, significantly overshadowed by its $20.8 billion in cash and cash equivalents. This financial strength underpins shareholder returns through repurchases and dividend payments. In April 2024, management approved a 4.8% dividend increase.
<h2>Other Stocks to Consider</h2>
Some other top-ranked stocks in the insurance space include CNO Financial Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>), MGIC Investment Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtg#NYSE">MTG</a>) and Palomar Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plmr#NASDAQ">PLMR</a>), each sporting a Zacks Rank #1 at present.
The bottom line of CNO Financial outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 21.21%. The Zacks Consensus Estimate for CNO&#39;s 2024 earnings suggests 11% year-over-year growth. The consensus mark for CNO Financial&#39;s 2024 earnings has moved north by 3% in the past 30 days.
MGIC Investment&#39;s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 15.59%. The Zacks Consensus Estimate for MTG&#39;s 2024 earnings indicates 9.1% year-over-year growth, while the same for revenues implies an improvement of 4.7%. MGIC Investment&#39;s consensus mark for 2024 earnings has moved north by 2.2% in the past 30 days.
The bottom line of Palomar outpaced estimates in each of the trailing four quarters, the average surprise being 17.10%. The Zacks Consensus Estimate for PLMR&#39;s 2024 earnings suggests 30.9% year-over-year growth, while the same for revenues implies an improvement of 41.6%. The consensus mark for Palomar&#39;s 2024 earnings has moved north by 1.3% in the past 30 days.
Shares of CNO Financial, MGIC Investment and Palomar have gained 24.2%, 22.4% and 18.3%, respectively, in the past three months.
<a href="https://www.zacks.com/stock/news/2336089/analyzing-metlife-stock-is-buy-strategy-the-right-move?cid=CS-BENZ-FT-analyst_blog|rank_focused-2336089">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Dividends

Management

Markets

Trading Ideas

PLMR

Analyzing MetLife Stock: Is Buy Strategy the Right Move?

CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $33.2, a high estimate of $38.00, and a low estimate of $29.00. This current average reflects an increase of 8.5% from the previous average price target of $30.60. 
<img src="https://www.benzinga.com/files/images/story/2024/1726243227_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of CNO Finl Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Underperform</td>
<td>$29.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$31.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$29.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CNO Finl Group. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CNO Finl Group compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of CNO Finl Group's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into CNO Finl Group's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CNO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CNO Finl Group analyst ratings.</a>
<h2>Unveiling the Story Behind CNO Finl Group</h2>
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
<h3>Breaking Down CNO Finl Group's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, CNO Finl Group showcased positive performance, achieving a revenue growth rate of 4.24% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: CNO Finl Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.91% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.85%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): CNO Finl Group's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.33%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.86, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Scoreboard: 5 Ratings For CNO Finl Group

Piper Sandler analyst John Barnidge reiterates CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Overweight and maintains $37 price target.

Reiteration

Piper Sandler Reiterates Overweight on CNO Finl Group, Maintains $37 Price Target

Shares of MGIC Investment Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtg#NYSE">MTG</a>)&nbsp;have rallied 23.8% year to date, outperforming the industry&#39;s growth of 12.7%, the Finance sector&#39;s rise of 10.4% and the Zacks S&amp;P 500 composite&#39;s increase of 16.8%. With a market capitalization of $6.2 billion, the average volume of shares traded in the last three months was 1.7 million.
Solid insurance in force, a decline in loss and claims payments, lower delinquency, better housing market fundamentals and prudent capital deployment drive this Zacks Rank #1 (Strong Buy) mortgage insurer.
MTG has a solid earnings surprise history. It surpassed estimates in each of the last four quarters, the average earnings surprise being 15.59%. Earnings of MTG have risen 8.7% over the last five years.
Return on invested capital in the trailing 12 months was 11.4%, better than the industry average of 2.4%, reflecting MTG&#39;s efficiency in utilizing funds to generate income.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4d/74483.jpg?v=1683554658" />
Image Source: Zacks Investment Research
<h3>Can the Stock Retain the Momentum?</h3>
New business, combined with increasing annual persistency, drives growth of the insurance-in-force portfolio. A higher level of new and existing home sales, increased percentage of homes purchased for cash and improved level of refinance activity in an improving housing market should help this largest private mortgage insurer in the United States retain the momentum.
MTG has been witnessing a declining pattern of claim filings. A decline in loss and claims will strengthen the balance sheet and improve the insurer&#39;s financial profile.
Banking on capital contribution, reinsurance transactions and cash position, the company has been improving its capital position. Both leverage and times interest earned ratios have been improving.
A solid capital position supports MTG in wealth distribution to shareholders via dividend hikes and share buybacks.&nbsp; The latest 13% increase in its quarterly dividend to 13 cents per share marked four straight years of dividend increases at a compound annual growth rate of 21%. The company currently has $724 million remaining in its authorization kitty through December 2026. Its share repurchase activity reflects continued strong mortgage credit performance.
The Zacks Consensus Estimate for 2024 earnings is pegged at $2.70 per share, suggesting an increase of 6.7% on 4.7% higher revenues of $1.2 billion. The consensus estimate for 2025 earnings per share is $2.72, suggesting an increase of 0.7% on 4.7% higher revenues of $1.3 billion. The long-term earnings growth rate is expected to be 6.8%.
The Zacks Consensus Estimate for 2024 and 2025 earnings has moved 7.1% and 4.6% north, respectively, in the past 30 days, reflecting analyst optimism.&nbsp;
<h3>Other Stocks to Consider</h3>
Other players in the insurance industry are CNO Financial Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>), Enact Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/act#NASDAQ">ACT</a>) and Kemper Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kmpr#NYSE">KMPR</a>), each sporting a Zacks Rank #1.
CNO Financial earnings surpassed estimates in three of the last four quarters and missed in one, the average beat being 21.21%. Year to date, CNO has rallied 16.5%.
The Zacks Consensus Estimate for CNO&#39;s 2024 and 2025 earnings implies 11% and 6.2% year-over-year growth, respectively.
Enact Holdings earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 13.96%. Year to date, ACT stock has surged 18%.
The Zacks Consensus Estimate for ACT&#39;s 2024 and 2025 earnings indicates 1% year-over-year growth each.
Kemper&#39;s earnings surpassed estimates in two of the last four quarters, missed in one and met estimates in one, the average earnings surprise being 6.93%. Year to date, KMPR stock has surged 28.6%.
The Zacks Consensus Estimate for KMPR&#39;s 2024 and 2025 earnings suggests 796.6% and 14.6% year-over-year growth, respectively.
<a href="https://www.zacks.com/stock/news/2323202/mgic-investment-mtg-gains-24-ytd-more-room-for-growth?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2323202">To read this article on Zacks.com click here.</a>

Buybacks

KMPR

MGIC Investment Gains 24% YTD: More Room for Growth?

CNO Financial Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>) reported second-quarter 2024 adjusted earnings per share of $1.05, which beat the Zacks Consensus Estimate by 45.8%. Moreover, the bottom line rose 94.4% year over year.
Total revenues increased 4.2% year over year to $1.07 billion in the second quarter. The top line beat the consensus mark by 16.4%.
The strong second-quarter results benefited from improved insurance product margin, premiums, and general account assets.&nbsp;However, the decline of the policyholder and other special-purpose portfolios partially offset the results.
<div class="chart_embed">
<h3>CNO Financial Group, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="CNO Financial Group, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/84/1722441570.png" style="height:265px; width:600px" title="" />
CNO Financial Group, Inc. price-consensus-eps-surprise-chart | CNO Financial Group, Inc. Quote
</div>
<h3>Second-Quarter Performance</h3>
Total insurance policy income of $641.5 million improved 2.1% year over year and beat the Zacks Consensus Estimate by 1.2% due to a rise in annuity, health and life insurance policy incomes.
CNO&#39;s net investment income increased 2.4% year over year to $409.1 million in the second quarter. General account assets grew 8.3% year over year to $351.7 million and beat the consensus mark by 14.1%. However, the policyholder and other special-purpose portfolios declined 37.3% year over year to $57.4 million.
Annuity collected premiums of $439.1 million increased 9.3% year over year. New annualized premiums for health and life products improved 4.3% year over year to $102.9 million. Annuity, Health and Life products accounted for 27.7%, 49.4% and 22.9%, respectively, of CNO&#39;s insurance margin.
Total benefits and expenses were $915.6 million, which declined 1.2% year over year. The decline in the metric was due to liability for future policy benefits remeasurement gain and a decline in other operating costs and expenses.
<h3>Financial Update (as of Jun 30, 2024)</h3>
CNO Financial exited the second quarter with unrestricted cash and cash equivalents of $878.8 million, which increased from the 2023-end level of $774.5 million. Total assets of $36.3 billion increased from $35.1 billion at 2023-end.
The debt-to-capital ratio was 43% at the end of the second quarter. It has no outstanding debt maturities till 2025.
Total shareholders&#39; equity jumped to $2.4 billion from $2.2 billion as of Dec 31, 2023.
Book value per diluted share increased to $36 in the second quarter from $33.94 at 2023-end. Adjusted operating return on equity came in at 11.2%, which improved from 8% a year ago.
<h3>Share Repurchase and Dividend Update</h3>
CNO Financial rewarded its shareholders with $60 million in the form of share buybacks and dividends of $17.2 million.
As of Jun 30, 2024, the company had remaining repurchase funds of $421.8 million.
<h3>2024 Guidance</h3>
<h3>New Update</h3>
CNO Financial now expects 2024 EPS in the range of $3.30-$3.50, indicating an increase of 10% from the 2023 figure of $3.09. The company expects the expense ratio to be in the range of 19%-19.2% for 2024, improving from the 2023 level of 19.4%. It expects $200-$250 million excess cash flow to the holding company.
<h3>Previous View</h3>
The company continues to anticipate the effective tax rate for 2024 to be around 23%. It is also aiming at a leverage of 25%-28% for this year.
<h3>Zacks Rank</h3>
CNO Financial currently carries a Zacks Rank #3 (Hold).
<h3>Performances of Other Insurers</h3>
Of the insurance industry players that have reported second-quarter 2024 results so far, the bottom-line results of&nbsp;Marsh &amp; McLennan Companies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>),&nbsp;Brown &amp; Brown, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Kinsale Capital Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knsl#NYSE">KNSL</a>) beat the Zacks Consensus Estimate.
Marsh &amp; McLennan reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year.&nbsp; Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.&nbsp; The top line, however, fell short of the consensus mark by 1%. MMC&#39;s adjusted operating income was $1.72 billion, which grew 11% year over year. Adjusted operating margin improved 130 bps year over year to 29%.
The Risk and Insurance Services segment&#39;s revenues were $4.02 billion, which advanced 8% year over year and 7% on an underlying basis. Adjusted operating income advanced 12% year over year to $1.34 billion. Revenues of Marsh, a unit within the segment, improved 8% year over year and 7% on an underlying basis to $3.27 billion. In the United States/Canada, underlying revenues grew 6% year over year. International operations also witnessed underlying revenue growth of 7%. &nbsp;
Brown &amp; Brown&#39;s second-quarter adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the consensus estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion.&nbsp;
Organic revenues improved 10% to $1 billion. Investment income more than doubled year over year to $22 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%.&nbsp;
Kinsale Capital delivered second-quarter net operating earnings of $3.75 per share, which outpaced the Zacks Consensus Estimate by 6.5%. The bottom line increased 30.4% year over year.&nbsp; Operating revenues jumped 45.1% year over year to $378 million. Revenues beat the consensus estimate of $377 million. Gross written premiums of $529.8 million rose 20.9% year over year. Net written premiums climbed 17.9% year over year to $430.2 million.&nbsp;
Net investment income increased 48.3% year over year to $35.8 million. Kinsale Capital&#39;s underwriting income was $76.1 million, which grew 23.6% year over year. The combined ratio deteriorated 100 bps to 77.7% in the quarter under review. The expense ratio deteriorated 10 bps to 21.1, while the loss ratio deteriorated 60 bps to 56.6.
<a href="https://www.zacks.com/stock/news/2313385/cno-financial-cno-q2-earnings-beat-estimates-24-eps-view-up?cid=CS-BENZ-FT-analyst_blog|earnings_article-2313385">To read this article on Zacks.com click here.</a>

Guidance

KNSL

CNO Financial Q2 Earnings Beat Estimates, '24 EPS View Up

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Benchmark cut the price target for iQIYI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) from $9 to $5 Benchmark analyst Fawne Jiang maintained a Buy rating. iQIYI shares rose 4% to trade at $3.3599 on Wednesday. S<a href="https://www.benzinga.com/quote/IQ/analyst-ratings">ee how other analysts view this stock</a>.</li>
<li>B of A Securities boosted the price target for Electronic Arts Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>) from $150 to $170. B of A Securities analyst Omar Dessouky maintained a Buy rating. Electronic Arts shares rose 2.3% to trade at $152.58 on Wednesday. <a href="https://www.benzinga.com/quote/EA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James increased Qorvo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) price target from $115 to $135. Keybanc analyst Justin Patterson maintained an Overweight rating. Qorvo shares fell 3.2% to trade at $115.59 on Wednesday. <a href="https://www.benzinga.com/quote/QRVO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Keybanc cut the price target for Pinterest, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) from $45 to $43. Mizuho analyst Brett Linzey maintained a Neutral rating. Pinterest shares fell 12.8% to trade at $32.54 on Wednesday. S<a href="https://www.benzinga.com/quote/PINS/analyst-ratings">ee how other analysts view this stock</a>.</li>
<li>JP Morgan raised Hubbell Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>) price target from $383 to $385. JP Morgan analyst Stephen Tusa maintained an Overweight rating. Hubbell shares rose 4.7% to trade at $397.54 on Wednesday. <a href="https://www.benzinga.com/quote/HUBS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Evercore ISI Group increased CNO Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) price target from $27 to $29. Evercore ISI Group analyst Thomas Gallagher maintained an Underperform rating. CNO Financial shares gained 1.1% to trade at $34.69 on Wednesday. S<a href="https://www.benzinga.com/quote/CNO/analyst-ratings">ee how other analysts view this stock</a>.</li>
<li>Craig-Hallum raised the price target for Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) from $125 to $140. Craig-Hallum analyst Anthony Stoss maintained a Buy rating. Skyworks shares fell 5.3% to trade at $111.51 on Wednesday.<a href="https://www.benzinga.com/quote/SWKS/analyst-ratings"> See how other analysts view this stock.</a></li>
<li>Baird boosted Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) price target from $355 to $375. Baird analyst Richard Eastman maintained an Outperform rating. Zebra Technologies shares rose 0.8% to trade at $350.86 on Wednesday. <a href="https://www.benzinga.com/quote/ZBRA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wedbush increased LendingClub Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) price target from $11 to $14. Wedbush analyst David Chiaverini maintained an Outperform rtaing. LendingClub shares rose 11.8% to trade at $12.51 on Wednesday. <a href="https://www.benzinga.com/quote/LC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo boosted Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) price target from $500 to $515. Wells Fargo analyst Michael Turrin maintained an Overweight rating. Microsoft shares fell 1.6% to trade at $416.07 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: &lt;a href=&#8221;https://www.benzinga.com/news/earnings/24/04/38307310/d-r-horton-netflix-and-3-stocks-to-watch-heading-into-thursday&#8221;&gt;&lt;em&gt; D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday &lt;/em&gt;&lt;/a&gt;

HUBB

MSFT

PINS

QRVO

SWKS

ZBRA

Microsoft To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Wednesday

Evercore ISI Group analyst Thomas Gallagher maintains CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Underperform and raises the price target from $27 to $29.

Evercore ISI Group Maintains Underperform on CNO Finl Group, Raises Price Target to $29

RBC Capital analyst Scott Heleniak maintains CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Outperform and raises the price target from $30 to $38.

RBC Capital Maintains Outperform on CNO Finl Group, Raises Price Target to $38

WIIM

CNO Financial shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 guidance.

U.S. stocks were mixed, with the Dow Jones index gaining more than 100 points on Tuesday.
Shares of PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) rose sharply during Tuesday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/40034498/fintech-giant-paypals-q2-earnings-revenue-and-eps-beat-payment-volumes-and-transactions-surge-guida">second quarter financial results</a>.
PayPal reported fiscal second-quarter revenue growth of 8% year over year to $7.89 billion, beating the analyst consensus estimate of $7.81 billion. The company reported a quarterly adjusted EPS of $1.19, beating analyst consensus estimates of 98 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
PayPal shares surged 8.5% to $63.98 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) jumped 20.6% to $7.16 after the company reported better-than-expected second-quarter financial results.</li>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) jumped 19.1% to $2.3050.</li>
<li>Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) jumped 19.1% to $146.77 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company raised its FY25 revenue guidance.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) jumped 18.8% to $13.96 after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares rose 15.9% to $98.13 after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>NeoGenomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) rose 16.1% to $17.00 following upbeat earnings.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) rose 16.1% to $2.1250 after the company reported better-than-expected quarterly financial results.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) climbed 15.5% to $97.79 after the company reported better-than-expected second-quarter financial results. Additionally, the company issued third-quarter earnings guidance above estimates.</li>
<li>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) gained 14.1% to $94.56 following better-than-expected second-quarter earnings, issued strong guidance, raised its dividend, increased its buyback authorization and issued strong guidance.</li>
<li>Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) rose 13.4% to $156.48 following -quarter earnings.</li>
<li>Varonis Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) jumped 13.3% to $54.92 as the company reported better-than-expected second-quarter financial results and raised its FY24 guidance on Monday.</li>
<li>Hayward Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NYSE">HAYW</a>) rose 11% to $14.98 after the company reported better-than-expected second-quarter EPS results.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares climbed 10.6% to $196.46 after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings guidance above estimates.</li>
<li>Heidrick &amp; Struggles International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSII#NASDAQ">HSII</a>) gained 10.2% to $39.41 following upbeat quarterly results.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares rose 9.8% to $8.28. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>CNO Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) jumped 9% to $33.78 following upbeat quarterly results.</li>
<li>Latham Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) surged 8.6% to $3.78.</li>
<li>Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) gained 8.1% to $104.28 after the company reported better-than-expected second quarter financial results. Additionally, the company revised its FY24 adjusted EPS forecast upward.</li>
<li>Eagle Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>) jumped 8.1% to $268.95 after the company reported better-than-expected first-quarter EPS results.</li>
<li>NovoCure Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) rose 8% to $22.47.</li>
<li>Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) gained 7.3% to $3.0802. Spirit Airlines announced low-fare travel with new premium offerings starting Aug. 2024.</li>
<li>Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) jumped 6.4% to $356.62 after the company reported better-than-expected quarterly financial results. Additionally, the company raised its FY24 guidance.</li>
<li>Gartner, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) rose 6.4% to $500.83 following better-than-expected quarterly earnings.</li>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) climbed 4.9% to $147.31 after the company reported better-than-expected quarterly financial results.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) gained 4.8% to $69.13.</li>
<li>American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) gained 4.3% to $10.88.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/40038432/mcdonalds-analysts-cut-their-forecasts-after-downbeat-earnings">McDonald&#8217;s Analysts Cut Their Forecasts After Downbeat Earnings</a></li>
</ul>

Intraday Update

Movers

CVLT

FFIV

HAYW

HLIT

HSII

JBLU

LUMN

NVCR

PEGA

PHAR

PYPL

RGEN

SAVE

SWIM

TLRY

VRNS

PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday

CNO Financial Group Raising Full-Year Guidance On Earnings And Cash Flow

CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.71 by 47.89 percent. This is a 94.44 percent increase over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $1.07 billion which beat the analyst consensus estimate of $943.98 million by 12.93 percent. This is a 4.31 percent increase over sales of $1.02 billion the same period last year.

CNO Finl Group Q2 Adj $1.05 Beats $0.71 Estimate, Sales $1.07B Beat $943.98M Estimate

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Market Perform and raises the price target from $30 to $31.

Keefe, Bruyette & Woods Maintains Market Perform on CNO Finl Group, Raises Price Target to $31

Cognizant Technology Solutions (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctsh#NASDAQ">CTSH</a>) benefits from an expanding portfolio with the recent launch of Neuro Edge, a new platform in its Neuro suite.
The solution empowers businesses across industries to harness the power of edge AI, enabling real-time decision-making and operational efficiency while reducing dependency on centralized servers and the cloud.
Neuro Edge supports a hybrid Cloud + Edge AI approach, ensuring data privacy, security and seamless integration with existing IT environments.
With applications spanning healthcare, manufacturing, retail, automotive and more, Cognizant is poised to transform enterprise capabilities in AI-driven edge computing.
<h3>Cognizant&#39;s Prospects Driven by Strong Partner Base</h3>
The latest move bodes well with CTSH&#39;s focus on enhancing AI capabilities and providing industry-specific solutions through the Cognizant Neuro Edge platform.
Further expanding its portfolio, Cognizant recently announced an agreement with Texas Dow Employees Credit Union (TDECU) to leverage its AI-driven Neuro IT Operations platform for enhancing operational efficiency, resilience and customer experience in TDECU&#39;s transformation journey.
Cognizant&#39;s robust partner base, which includes the likes of Gentherm (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>), Microsoft&nbsp;and CNO Financial Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>), is a critical catalyst. Its robust pipeline, which includes a favorable mix of new opportunities, is noteworthy.
In first-quarter 2024, CTSH demonstrated significant improvement in securing large deals, winning several contracts worth more than $100 million each.
The company recently collaborated with Gentherm to provide engineering services, including systems engineering, validation and model-based development, aiming to enhance agility and scalability in product development through cloud-native technologies and virtualization.
In April, Cognizant, in collaboration with Microsoft, announced an expanded partnership aiming to leverage generative AI and Copilots to drive innovation across industries, focusing on transforming enterprise operations and enhancing employee experiences.
In first-quarter 2024 Cognizant announced the continuation of its partnership with CNO Financial, a leading provider of insurance, financial services, and workforce benefits solutions to middle-income America. Cognizant will help in optimizing and enhancing CNO Financials&#39; technology-based services and solutions with cloud and digital technologies.
<h3>Conclusion</h3>
Despite an expanding portfolio and a strong partner base, weakness in the Financial Services segment negatively impacted Cognizant&#39;s top line.
In first-quarter 2024, revenues of $4.76 billion saw a year-over-year decline of 1.1% and 1.2% at constant currency (cc). The Financial Services revenues dropped 6.2% year over year to $1.38 billion during this period.
The company&#39;s shares have declined 10.3% against the Zacks Computer &amp; Technology sector&#39;s growth of 24.5% year to date.
This Zacks Rank #2 (Buy) company expects second-quarter 2024 revenues to be between $4.75 billion and $4.82 billion, indicating a decline of 2.9% to 1.4% (a decline of 2.5-1% at cc).
The Zacks Consensus Estimate for second-quarter revenues is pegged at $4.81 billion, indicating a decline of 1.63% from year-ago levels.
The consensus mark for earnings is pegged at $1.12 per share, unchanged in the past 30 days.
<a href="https://www.zacks.com/stock/news/2296262/cognizant-ctsh-expands-neuro-suite-with-edge-ai-platform?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2296262">To read this article on Zacks.com click here.</a>

Small Cap

Tech

CTSH

THRM

Cognizant Expands Neuro Suite With Edge AI Platform

Piper Sandler analyst John Barnidge maintains CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) with a Overweight and raises the price target from $29 to $31.

Piper Sandler Maintains Overweight on CNO Finl Group, Raises Price Target to $31

CNO Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) announced today that its Board of Directors has approved a $0.01 per share increase in its quarterly dividend, its twelfth consecutive annual increase. The Board declared a quarterly cash dividend of $0.16 per share on the company's common shares. The dividend will be payable June 24, 2024, to shareholders of record at the close of business on June 10, 2024.

CNO Financial Group Announces Increase Of Quarterly Dividend From $0.15 To $0.16

Dividend Champion, Contender, And Challenger Highlights: Week Of September 22

Piper Sandler analyst John Barnidge maintained a Buy rating on CNO Financial (CNO – Research Report) today and set a price target of $38.00. The co...

Piper Sandler Reaffirms Their Buy Rating on CNO Financial (CNO)

Reports Q3 revenue $1.13B, consensus $945.44M. "CNO delivered another quarter of excellent net operating income and sales performance, reflecting c...

CNO Financial reports Q3 operating EPS $1.11, consensus 82c

CNO Financial GAAP EPS of $0.09 misses by $0.75, revenue of $1.13B beats by $184.55M

CNO Financial Group, Inc. 2024 Q3 - Results - Earnings Call Presentation

CNO Financial Group, Inc. (CNO) Q3 2024 Earnings Call Transcript

CNO Financial Group ( ($CNO) ) has released its Q3 earnings. Here is a breakdown of the information CNO Financial Group presented to its investors....

CNO Financial Group Reports Strong Q3 2024 Results

RBC Capital analyst Scott Heleniak maintained a Buy rating on CNO Financial (CNO – Research Report) on November 1 and set a price target of $40.00....

RBC Capital Remains a Buy on CNO Financial (CNO)

Evercore ISI raised the firm's price target on CNO Financial (CNO) to $40 from $35 and keeps an Underperform rating on the shares. The firm thinks ...

CNO Financial price target raised to $40 from $35 at Evercore ISI

Meetings to be held in Chicago November 14-15 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving...

CNO Financial management to meet with Piper Sandler

ALLE

AMCR

AUBN

AVGO

BANF

BSVN

COFS

CSGS

CSWC

CTRE

CZFS

EFSC

ENSG

EPRT

FBNC

FCPT

FFMR

FITB

FMNB

FSFG

GAIN

GATX

GILD

GNTY

GSBC

GWRS

HLAN

HOFT

IIPR

INVH

IROQ

ISTR

JKHY

KFRC

LANC

LAND

LDOS

LECO

LOGI

MDLZ

MPWR

NDAQ

NXRT

OCSL

OFLX

OLED

PINE

PLOW

PNBI

POWI

QCOM

QNBC

REXR

STAG

STLD

TFII

TOWN

TRNO

TROW

VCTR

VRSK

XRAY

YORW

Press Releases

CNO Financial Group Renews Title Sponsorship of the Indianapolis Monumental Marathon Through 2026

Insurance

CNO Financial Group to Release Second Quarter Results on July 29, 2024

CNO Financial Group Reports Second Quarter 2024 Results

CNO Financial Group Declares $0.16 Quarterly Dividend

CNO Financial Group to Present at the 2024 KBW Insurance Conference on September 5

Washington National Introduces New Hospital Indemnity Insurance Product

Fintech

CNO Financial Group Appoints Jess Turner to its Board of Directors

CNO Financial Group to Release Third Quarter Results on October 31, 2024

CNO Financial Group Reports Third Quarter 2024 Results

A Monumental Record-Breaking Day at the 2024 CNO Financial Indianapolis Monumental Marathon

Comments

CNO Finl Group

Vendite allo scoperto

CNO Finl Group (NYSE:CNO) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO